Form DEFA14A Vanda Pharmaceuticals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. MSFT
6. NAVN
7. DFTX
8. CNC
9. KFY
10. SPY

April 23, 2026 7:20 PM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
SCHEDULE 14A
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.    ) 
Filed by the Registrant  x                Filed by a Party other than the Registrant  o 
Check the appropriate box:
 
o 
 Preliminary Proxy Statement
o 
 Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o 
 Definitive Proxy Statement
x  
 Definitive Additional Materials
o 
 Soliciting Material Pursuant to §240.14a-12
Vanda Pharmaceuticals Inc.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
x
No fee required.
o
Fee paid previously with preliminary materials.
o
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.



supplementalproxymaterials.jpg




supplementalproxymaterialsa.jpg


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings